Evidence map›Paper›PMID 37132204›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2023

Vaccination Status and Trends in Adult Coronavirus Disease 2019-Associated Hospitalizations by Race and Ethnicity: March 2020-August 2022.

Jean Y Ko, Huong Pham, Onika Anglin, Shua J Chai, Nisha B Alden, James Meek, Evan J Anderson, Andy Weigel, Alexander Kohrman, Ruth Lynfield and 10 more

Open access · hybridAbstract readComparative Study
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 12 institutions in 1 country.

Jean Y KoCenters for Disease Control and Prevention COVID-19 Response, Atlanta, Georgia, USA.ORCID 0000-0003-0961-9793
Huong PhamCenters for Disease Control and Prevention COVID-19 Response, Atlanta, Georgia, USA.
Onika AnglinCenters for Disease Control and Prevention COVID-19 Response, Atlanta, Georgia, USA.
Shua J ChaiCalifornia Emerging Infections Program, Oakland, California, USA.
Nisha B AldenColorado Department of Public Health and Environment, Denver, Colorado, USA.
James MeekConnecticut Emerging Infections Program, Yale School of Public Health, New Haven, Connecticut, USA.
Evan J AndersonEmory University School of Medicine, Atlanta, Georgia, USA.
Andy WeigelIowa Department of Public Health, Des Moines, Iowa, USA.
Alexander KohrmanMichigan Department of Health and Human Services, Lansing, Michigan, USA.
Ruth LynfieldMinnesota Department of Health, St. Paul, Minnesota, USA.
Dominic RudinNew Mexico Emerging Infections Program, Albuquerque, New Mexico, USA.
Grant BarneyNew York State Department of Health, Albany, New York, USA.
Nancy M BennettUniversity of Rochester School of Medicine and Dentistry, Rochester, New York, USA.
Laurie M BillingOhio Department of Health, Columbus, Ohio, USA.
Melissa SuttonPublic Health Division, Oregon Health Authority, Portland, Oregon, USA.
H Keipp TalbotVanderbilt University Medical Center, Nashville, Tennessee, USA.
Ashley SwainSalt Lake County Health Department, Salt Lake City, Utah, USA.
Fiona P HaversCenters for Disease Control and Prevention COVID-19 Response, Atlanta, Georgia, USA.
Christopher A TaylorCenters for Disease Control and Prevention COVID-19 Response, Atlanta, Georgia, USA.
COVID-NET Surveillance Team
Centers for Disease Control and Prevention · USOregon Health Authority · USUniversity of Rochester · USColorado Department of Public Health and Environment · USEmory University · USIowa Department of Public Health · USLake County · USMichigan Department of Health and Human Services · USMinnesota Department of Health · USNew York State Department of Health · USOhio Department of Health · USVanderbilt University Medical Center · US

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

backgroundWe sought to determine whether race/ethnicity disparities in severe coronavirus disease 2019 (COVID-19) outcomes persist in the era of vaccination.

methodsPopulation-based age-adjusted monthly rate ratios (RRs) of laboratory-confirmed COVID-19-associated hospitalizations were calculated among adult patients from the COVID-19-Associated Hospitalization Surveillance Network, March 2020 - August 2022 by race/ethnicity. Among randomly sampled patients July 2021 - August 2022, RRs for hospitalization, intensive care unit (ICU) admission, and in-hospital mortality were calculated for Hispanic, Black, American Indian/Alaskan Native (AI/AN), and Asian/Pacific Islander (API) persons vs White persons.

resultsBased on data from 353 807 patients, hospitalization rates were higher among Hispanic, Black, and AI/AN vs White persons March 2020 - August 2022, yet the magnitude declined over time (for Hispanic persons, RR = 6.7; 95% confidence interval [CI], 6.5-7.1 in June 2020 vs RR < 2.0 after July 2021; for AI/AN persons, RR = 8.4; 95% CI, 8.2-8.7 in May 2020 vs RR < 2.0 after March 2022; and for Black persons RR = 5.3; 95% CI, 4.6-4.9 in July 2020 vs RR < 2.0 after February 2022; all P ≤ .001). Among 8706 sampled patients July 2021 - August 2022, hospitalization and ICU admission RRs were higher for Hispanic, Black, and AI/AN patients (range for both, 1.4-2.4) and lower for API (range for both, 0.6-0.9) vs White patients. All other race and ethnicity groups had higher in-hospital mortality rates vs White persons (RR range, 1.4-2.9).

conclusionsRace/ethnicity disparities in COVID-19-associated hospitalizations declined but persist in the era of vaccination. Developing strategies to ensure equitable access to vaccination and treatment remains important.

Indexed as

COVID-19COVID-19 VaccinesEthnicityAdultAmerican Indian or Alaska NativeAsian American Native Hawaiian and Pacific IslanderAsian PeopleBlack or African AmericanHispanic or LatinoHospitalizationHospital MortalityHumansIntensive Care UnitsRacial GroupsUnited StatesWhiteCOVID-19 VaccinesCOVID-19–associated hospitalizationsrace and ethnicitytrends

Identifiers

PMID37132204
PMCPMC11019819
OpenAlexW4367833784

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.